5-ALA induced PpIX fluorescence spectroscopy in neurosurgery: a review.

5-aminolevulinic acid (5-ALA) brain tumors fluorescence guided surgery fluorescence spectroscopy image guidance neurooncology neurosurgery protoporphyrin IX (PpIX)

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2024
Historique:
received: 09 10 2023
accepted: 02 01 2024
medline: 13 2 2024
pubmed: 13 2 2024
entrez: 13 2 2024
Statut: epublish

Résumé

The review begins with an overview of the fundamental principles/physics underlying light, fluorescence, and other light-matter interactions in biological tissues. It then focuses on 5-aminolevulinic acid (5-ALA)-induced protoporphyrin IX (PpIX) fluorescence spectroscopy methods used in neurosurgery (e.g., intensity, time-resolved) and in so doing, describe their specific features (e.g., hardware requirements, main processing methods) as well as their strengths and limitations. Finally, we review current clinical applications and future directions of 5-ALA-induced protoporphyrin IX (PpIX) fluorescence spectroscopy in neurosurgery.

Identifiants

pubmed: 38348134
doi: 10.3389/fnins.2024.1310282
pmc: PMC10859467
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1310282

Informations de copyright

Copyright © 2024 Gautheron, Bernstock, Picart, Guyotat, Valdés and Montcel.

Déclaration de conflit d'intérêts

PV is a consultant for an unrelated imaging study for NX Development Corp and has multiple patents or provisional patents on fluorescence imaging technologies for fluorescence-guided neurosurgery. PV and JB have equity in Lumiere Optix. JB has an equity position in Treovir Inc. and UpFront Diagnostics. JB is also on the Centile Bioscience, QV Bioelectronics, and NeuroX1 boards of scientific advisors. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

A Gautheron (A)

Université Jean Monnet Saint-Etienne, CNRS, Institut d Optique Graduate School, Laboratoire Hubert Curien UMR 5516, Saint-Étienne, France.
Univ Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1294, Lyon, France.

J D Bernstock (JD)

Department of Neurosurgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.

T Picart (T)

Department of Neurosurgical Oncology and Vascular Neurosurgery, Pierre Wertheimer Neurological and Neurosurgical Hospital, Hospices Civils de Lyon, Lyon, France.
Université Lyon 1, INSERM 1052, CNRS 5286, Lyon, France.

J Guyotat (J)

Department of Neurosurgical Oncology and Vascular Neurosurgery, Pierre Wertheimer Neurological and Neurosurgical Hospital, Hospices Civils de Lyon, Lyon, France.

P A Valdés (PA)

Department of Neurosurgery, University of Texas Medical Branch, Galveston, TX, United States.
Department of Neurobiology, University of Texas Medical Branch, Galveston, TX, United States.
Department of Electrical and Computer Engineering, Rice University, Houston, TX, United States.

B Montcel (B)

Univ Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, U1294, Lyon, France.

Classifications MeSH